ATG-101 – Patient Worthy

https://pixabay.com/en/dna-helix-curve-science-medicine-869109/

ATG-101 for Pancreatic Cancer Earns Orphan Drug Designation

Post author:Jessica Lynn
Post published:September 29, 2022
Post category:Pancreatic Cancer

In the United States, the FDA grants Orphan Drug designation to drugs or biologics intended to prevent, diagnose, or treat rare conditions. These are conditions affecting fewer than 200,000 Americans.…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More